Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 –Mutated Metastatic Colorectal Cancer.Published in:Cancers, 2022, v. 14, n. 23, p. 5921, doi. 10.3390/cancers14235921By:Lahoz, Sara;Rodríguez, Adela;Fernández, Laia;Gorría, Teresa;Moreno, Reinaldo;Esposito, Francis;Oliveres, Helena;Albiol, Santiago;Saurí, Tamara;Pesantez, David;Riu, Gisela;Cuatrecasas, Miriam;Jares, Pedro;Pedrosa, Leire;Pineda, Estela;Postigo, Antonio;Castells, Antoni;Prat, Aleix;Maurel, Joan;Camps, JordiPublication type:Article